Furthermore, norepinephrine’s activation of ADRB2 triggers the cAMP-PKA signaling cascade in endothelial cells, indicating that targeting cAMP may represent a viable strategy to inhibit tumor-associated angiogenesis (79). The gene discussed is ADRB2; the disease is neoplasm.